References
- Qu S, Xu Z, Zhang Y, . Impacts of cytogenetic categories in the Revised International Prognostic Scoring System on the prognosis of primary myelodysplastic syndromes: results of a single-center study. Leuk Lymphoma 2011 Dec 6. [Epub ahead of print]
- Greenberg P, Cox C, LeBeau M, . International International Scoring System for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079–2088.
- Morel P, Hebbar M, Lai J, . Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993;7:1315–1323.
- Solé F, Luño E, Sanzo C, . Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica 2005;90:1168–1178.
- Parlier V, van Melle G, Beris P, . Prediction of 18-month survival in patients with primary myelodysplastic syndrome. A regression model and scoring system based on the combination of chromosome findings and Bournemouth score. Cancer Genet Cytogenet 1995;81:158–165.
- Haase D, Germing U, Schanz J, . New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007; 110:4385–4395.
- Belli C, Bengió R, Negri Aranguren P, . Partial and total monosomal karyotypes in myelodysplastic syndromes: comparative prognostic relevance among 421 patients. Am J Hematol 2011;86: 540–545.
- Schanz J, Tüchler H, Sole F, . Proposal of a new, comprehensive cytogenetic scoring system for primary MDS. Haematologica 2010;95(Suppl. 2): Abstract 535.
- Breems DA, Van Putten WL, De Greef GE, . Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008;26:4791–4797.
- Bennett J, Catovsky D, Daniel M, . Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189–199.
- Harris NL, Jaffe ES, Diebold J, . World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835–3849.
- Malcovati L, Germing U, Kuendgen A, . Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007;25: 3503–3510.
- Belli C, Acevedo S, Bengio R, . Detection of risk groups in myelodysplastic syndrome. A multicenter study. Haematologica 2002;87:9–16.
- Kantarjian H, O'Brien S, Ravandi F, . Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 2008;113:1351–1361.
- Patnaik MM, Hanson CA, Hodnefield JM, . Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia 2011;25:266–270.